Project Energy Reimagined Acquisition Corp.
(NASDAQ: PEGR) |
$10.820 |
$188.54M |
-1.10% |
ProMIS Neurosciences Inc.
(NASDAQ: PMN) |
$2.160 |
$41.52M |
-1.78% |
ProPhase Labs Inc.
(NASDAQ: PRPH) |
$3.320 |
$62.58M |
+3.11% |
ProQR Therapeutics N.V.
(NASDAQ: PRQR) |
$1.870 |
$153.53M |
+6.86% |
Protagenic Therapeutics Inc.
(NASDAQ: PTIX) |
$0.768 |
$3.21M |
+2.40% |
Protalix BioTherapeutics Inc.
(NYSE American: PLX) |
$1.165 |
$85.78M |
+1.30% |
Protara Therapeutics Inc.
(NASDAQ: TARA) |
$2.400 |
$49.42M |
+0.84% |
Provident Bancorp Inc.
(NASDAQ: PVBC) |
$11.875 |
$209.41M |
+3.26% |
Provident Financial Holdings Inc.
(NASDAQ: PROV) |
$12.840 |
$87.56M |
+2.47% |
Psychemedics Corporation
(NASDAQ: PMD) |
$2.430 |
$13.35M |
+4.74% |
Psyence Biomedical Ltd.
(NASDAQ: PBM) |
$0.453 |
$5.88M |
+27.82% |
Pulmatrix Inc.
(NASDAQ: PULM) |
$2.000 |
$7.67M |
-2.63% |
Puma Biotechnology Inc
(NASDAQ: PBYI) |
$3.940 |
$190.54M |
+7.65% |
Pure Cycle Corporation
(NASDAQ: PCYO) |
$10.980 |
$264.11M |
+5.48% |
PureCycle Technologies Inc.
(NASDAQ: PCTTW) |
$1.390 |
$303.51M |
+2.39% |
PureCycle Technologies, Inc.
(NASDAQ: PCT) |
$6.010 |
$989.43M |
+3.98% |
Purple Biotech Ltd.
(NASDAQ: PPBT) |
$0.384 |
$12.84M |
+1.00% |
Purple Innovation Inc.
(NASDAQ: PRPL) |
$1.475 |
$158.01M |
+22.92% |
Pyxis Oncology Inc.
(NASDAQ: PYXS) |
$3.560 |
$209.64M |
+11.25% |
Pyxis Tankers Inc.
(NASDAQ: PXS) |
$4.960 |
$52.28M |
+0.81% |